Pediatric Cancer Models and Mechanisms network
The PCMM network will: catalyze innovation and accelerate translation in precision pediatric cancer; establish a core national platform to foster research excellence; enable equity for pediatric patients across Canada by promoting national access to preclinical innovation while supporting the principles of diversity and inclusion; and, enhance our national ability to be nimble in the development of preclinical data to support early phase trials.
Primary target audience is researchers in the field of pediatric oncology